Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

NCT02239120 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5390

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke
Secondary Prevention

Interventions

DRUG: optional ASA as comedication
DRUG: placebo to ASA
DRUG: placebo to optional ASA as comedication
DRUG: placebo to dabigatran etexilate
DRUG: ASA 100 mg
DRUG: dabigatran etexilate

Sponsor

Boehringer Ingelheim